The Parkinson Progression Marker Initiative (PPMI)Kenneth Marek, Marne Baca, Sohini Chowdhury et al.|Progress in Neurobiology|2011Cited by 1.9k
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive declineP. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman et al.|Neurology|2012Cited by 228
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological ImplicationsHonglei Chen, Jing Zhang, Edward A. Burton et al.|Environmental Health Perspectives|2013Cited by 81
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease SubjectsOlivier Barret, Danna Jennings, David Alagille et al.|Journal of Nuclear Medicine|2016Cited by 77
P4‐351: Evaluation of TAU Burden in a Cross‐Sectional Cohort of Alzheimer’S Disease Subjects Using [<sup>18</sup>F]GTP1 (GENENTECH TAU PROBE 1)Sandra Sanabria Bohórquez, Geoffrey A. Kerchner, Olivier Barret et al.|Alzheimer s & Dementia|2016Cited by 14